T-cell receptor genes in autoimmunity

Area of Science:

• Immunology
• Autoimmune Diseases
• T-cell Receptor (TCR) Biology

Background:

• T cells are central to Major Histocompatibility Complex (MHC)-dependent autoimmune diseases.
• Research has sought evidence linking T-cell receptor (TCR) V-gene repertoires to these disorders.
• Previous studies show limited clear-cut evidence for specific genomic polymorphisms correlating with autoimmune disease predisposition.

Purpose of the Study:

• To review the evidence for the association of T-cell receptor (TCR) V-gene repertoires with autoimmune diseases.
• To evaluate the potential for therapeutic interventions targeting TCRs in autoimmune conditions.

Main Methods:

• Review of existing literature on TCR V-gene usage in animal models and human autoimmune diseases.
• Analysis of studies investigating T-cell responses to autoantigens like myelin basic protein.
• Consideration of factors contributing to variability in TCR V-gene utilization across studies and patients.

Main Results:

• Restricted use of certain V beta and V alpha genes observed in animal models responding to specific autoantigens.
• In human autoimmune diseases, TCR V-gene usage is often not absolutely restricted and shows significant inter-individual variation.
• Variability may stem from MHC allele-dependent mechanisms, secondary T-cell infiltrates, diverse patient populations, disease stages, or different pathogens.

Conclusions:

• Therapeutic strategies based on modified T-cell clones, V-region peptides, or TCR blocking analogues may face challenges in broad applicability.
• Further research is needed to characterize specific antigens involved in autoimmune pathogenesis to better understand TCR utilization.
• Accurate antigen identification is crucial for developing targeted immunotherapies for autoimmune diseases.